English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#biotech search results

ORF_CNED's profile picture. CNED @orfonline seeks to strengthen the multi-stakeholder response to the important challenges and opportunities facing the global community.
The Centre for New Economic Diplomacy
@ORF_CNED
10 h

#Budget2026 lays out a two-track manufacturing strategy: building capability in technology-intensive sectors like #semiconductors and #biotech, while sustaining labour-intensive industries to scale jobs and diversify exports. Balance, not trade-offs, defines #India’s industrial

ORF_CNED's tweet card. Industrial Policy in Budget 2026–27 outlines a two-track manufacturing strategy—deepening capabilities in technology-intensive sectors while sustaining scale and employment in labour-intensive...
Industrial Policy in Budget 2026–27: Balancing Capability and Scale
Source: orfonline.org
0
0
0
0
20
anger_trading's profile picture. Personal TG low cap alpha: https://t.co/CkR90H22LM I talk about coins I own and like. No paid promos. Not a KOL.
AngerTrading 🧘‍♂️
@anger_trading
Apr 20

Study one of the few #BioTech gems in web-3 $BioLLM @BioLLM_ 👇

RoundtableSpace's profile picture. @MarioNawfal’s Crypto & AI Account
0xMarioNawfal
@RoundtableSpace
Apr 15

SCIENTISTS CONNECTED LIVING HUMAN BRAIN CELLS TO AN AI MODEL TO INFLUENCE ITS DECISIONS

24
20
70
22
51K
4
3
17
2
1K
EURESJob's profile picture. EURES supports EU/EEA resident jobseekers to work abroad, and employers to recruit international employees. #EURESjobs
EURES
 @EURESJob
Apr 15

If you're a professional in #ICT, #biotech or #cleantech, Valais is hiring! Join the #WorkinginValais event on 23 April from 10:00 to 12:30 CET to: 💼 Browse open vacancies 🤝 Chat with employers 📝 Learn about working in Valais Register 👉 europeanjobdays.eu/en/event/work-… #EURESJobs

EURESJob's tweet image. If you're a professional in #ICT, #biotech or #cleantech, Valais is hiring! Join the #WorkinginValais event on 23 April from 10:00 to 12:30 CET to: 💼 Browse open vacancies 🤝 Chat with employers 📝 Learn about working in Valais Register 👉 europeanjobdays.eu/en/event/work-… #EURESJobs
1
1
2
1
448
moneywisecom's profile picture. https://t.co/JgvFH3AJSZ delivers trending stories, financial tips and tricks, and market insights to millions of readers. Follow us and read it first.
Moneywise
@moneywisecom
13 h

Goldman Sachs warned 'curing patients isn't a sustainable business model' in 2018 — 8 years later, biotech is quietly proving the bank right #Biotech #Investing #PersonalFinance moneywise.com/news/top-stori…

moneywisecom's tweet card. Many new gene therapy treatments aren’t as profitable as predicted. But the reasons why don’t quite fit Goldman Sachs’ warning
Goldman Sachs warned 'curing patients isn't a sustainable business model' in 2018 — 8 years later,...
Source: moneywise.com
0
0
0
0
91
PatrickHwuMD's profile picture. Moffitt Cancer Center President and CEO, @MoffittNews. Tumor immunologist. Inspired leader. Girl dad. #DocsWhoRock. Driven to save more lives from #cancer.
Dr. Patrick Hwu
@PatrickHwuMD
Apr 10

Getting #MoffittBOB started @MoffittNews with an economic development breakfast, welcoming key leaders for a chat about the future of #biotech in our region. Thanks to Tim Plett, Executive Director, Life Sciences and Commercial Banking @jpmorgan for a great presentation.

PatrickHwuMD's tweet image. Getting #MoffittBOB started @MoffittNews with an economic development breakfast, welcoming key leaders for a chat about the future of #biotech in our region. Thanks to Tim Plett, Executive Director, Life Sciences and Commercial Banking @jpmorgan for a great presentation.
PatrickHwuMD's tweet image. Getting #MoffittBOB started @MoffittNews with an economic development breakfast, welcoming key leaders for a chat about the future of #biotech in our region. Thanks to Tim Plett, Executive Director, Life Sciences and Commercial Banking @jpmorgan for a great presentation.
1
3
11
1
512
orfgeotech's profile picture. Centre for Security, Strategy & Technology @orfonline.
ORF GeoTech
@orfgeotech
2 h

#AI–#biotech convergence and civil–#military applications heighten dual-use risks, making norms, multilateral frameworks, and the Biological Weapons Convention essential to safeguard innovation while managing #security: @lakshmyrkrish or-f.org/37605

orfgeotech's tweet card. Treating biotechnology as a strategic security asset deepens the dual-use dilemma, fuels techno-nationalist competition, fragments research cooperation, and risks worsening biosecurity unless managed...
Governing Biotechnology’s Dual-Use Security Dilemma
Source: orfonline.org
0
0
0
0
9
LongevityTech's profile picture. Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity
Longevity Technology
 @LongevityTech
Apr 14

Oral Alzheimer’s pipeline advances as biotech pushes for scalable, disease-modifying treatments beyond infusions. ㅤ Link in bio. ㅤ #longevity #alzheimers #biotech #healthspan #innovation

LongevityTech's tweet image. Oral Alzheimer’s pipeline advances as biotech pushes for scalable, disease-modifying treatments beyond infusions. ㅤ Link in bio. ㅤ #longevity #alzheimers #biotech #healthspan #innovation
0
2
11
0
590
StockheadAU's profile picture. Big discoveries, amazing science, hot technology: Stockhead publishes exclusive news about emerging ASX-listed companies.
Stockhead
 @StockheadAU
3 h

Biocurious by Tim Boreham: A string of ASX drug developers are approaching pivotal clinical trial readouts in 2026 — here's what investors should have on their radar. #ASX #Biotech $DXB $CYP $RCE $NTI buff.ly/LQH31jG

StockheadAU's tweet card. A string of ASX-listed drug developers is due to release company-making – or breaking – pivotal clinical study results in coming months.
Biocurious: Stay tuned as drug developers get to the pointy end of their efforts | Stockhead
Source: stockhead.com.au
0
0
0
3
216
biospace's profile picture. Your source for biopharma news and jobs
BioSpace
 @biospace
Apr 15

Leading Beeline Medicines’ pipeline is afimetoran, which is in Phase 2 development for systemic lupus erythematosus with data expected later this year. #biotech #biospace hubs.li/Q04c791X0

biospace's tweet card. Leading Beeline Medicines’ pipeline is afimetoran, which is in Phase 2 development for systemic lupus erythematosus with data expected later this year.
BMS makes a Beeline, bringing 5 assets to biotech's $300M precision immunology debut
Source: biospace.com
1
0
2
1
247
orfgeotech's profile picture. Centre for Security, Strategy & Technology @orfonline.
ORF GeoTech
@orfgeotech
11 h

#AI–#biotech convergence and civil–#military applications heighten dual-use risks, making norms, multilateral frameworks, and the Biological Weapons Convention essential to safeguard innovation while managing #security: @lakshmyrkrish or-f.org/37605

orfgeotech's tweet card. Treating biotechnology as a strategic security asset deepens the dual-use dilemma, fuels techno-nationalist competition, fragments research cooperation, and risks worsening biosecurity unless managed...
Governing Biotechnology’s Dual-Use Security Dilemma
Source: orfonline.org
0
0
0
0
14
LongevityTech's profile picture. Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity
Longevity Technology
 @LongevityTech
Apr 17

RNA editing enters the clinic as AIRNA doses its first patient, advancing a new class of therapies that repair genetic mutations without altering DNA. ㅤ Link in bio. ㅤ #longevity #biotech #rna #healthspan #innovation

LongevityTech's tweet image. RNA editing enters the clinic as AIRNA doses its first patient, advancing a new class of therapies that repair genetic mutations without altering DNA. ㅤ Link in bio. ㅤ #longevity #biotech #rna #healthspan #innovation
0
7
25
6
857
ISS_CASIS's profile picture. The International Space Station National Laboratory is managed by the Center for the Advancement of Science in Space (CASIS).
ISS National Lab
 @ISS_CASIS
15 h

In microgravity, cells can’t always access what they need to produce efficiently. Fixing space manufacturing may mean redesigning how they’re grown: ow.ly/ACfQ50YJXoK #SpaceBiology #Microgravity #Biotech #ISSResearch #Innovation #SpaceX

ISS_CASIS's tweet image. In microgravity, cells can’t always access what they need to produce efficiently. Fixing space manufacturing may mean redesigning how they’re grown: ow.ly/ACfQ50YJXoK #SpaceBiology #Microgravity #Biotech #ISSResearch #Innovation #SpaceX
0
3
10
1
628
WassimLaroussi3's profile picture. Just an ordinary guy with a YouTube Channel. Not financial advice. Opinions are my own. $ARQT $COGT $IDYA $KURA $RARE
Wassim Laroussi
@WassimLaroussi3
Apr 19

Here is a deep dive into Cogent Biosciences $COGT I break down: Summit, Apex, and Peak trial data Bezoclastinib’s safety vs. competitors Bull/Bear valuation scenarios Watch here: youtu.be/z5aF_aWZsqI #Biotech #Investing #COGT #Stocks

WassimLaroussi3's tweet card. The Biotech Investor

youtube.com

YouTube

The Biotech Investor

Source: youtube.com
1
1
22
11
3K
LongevityTech's profile picture. Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity
Longevity Technology
 @LongevityTech
Apr 15

FDA fast-tracks a bioengineered liver technology, accelerating efforts to address organ shortages with regenerative solutions. ㅤ Link in bio. ㅤ #longevity #biotech #healthspan #innovation #regenerativemedicine

LongevityTech's tweet image. FDA fast-tracks a bioengineered liver technology, accelerating efforts to address organ shortages with regenerative solutions. ㅤ Link in bio. ㅤ #longevity #biotech #healthspan #innovation #regenerativemedicine
0
7
16
1
1K
PatrickHwuMD's profile picture. Moffitt Cancer Center President and CEO, @MoffittNews. Tumor immunologist. Inspired leader. Girl dad. #DocsWhoRock. Driven to save more lives from #cancer.
Dr. Patrick Hwu
@PatrickHwuMD
Apr 10

Excited to welcome more than 800 attendees to the 19th annual Business of Biotech conference @MoffittNews. From early-stage innovation to clinical impact, the conference aims to spark connection, accelerate ideas and bring together the people driving what’s next in #biotech.

1
5
21
1
1K
etelligenz's profile picture.
etelligenz
 @etelligenz
now

Breaking: Amazon Bio Discovery compressed a year of cancer research into 3 weeks. 🧬💊 "Lab-in-the-Loop" AI is here, turning biological foundation models into autonomous cure-seekers. etelligenz.com/blog/amazon-bi… #AI #BioTech #HealthTech

0
0
0
0
0
10BaggerStocksX's profile picture. 10 Bagger Stocks Canada: Canada’s top stock market source. 95,000 followers on Instagram! Not financial advice
10 Bagger Stocks Canada
@10BaggerStocksX
1 h

Cipher Pharmaceuticals (TSX: CPH) stock informative reel #biotech #stocks #tsx #canada Disclaimer: I currently own shares in Cipher Pharmaceuticals (TSX: CPH). All statements and opinions expressed are my own and for informational and discussion purposes only. This is not

0
0
1
0
37
3in5saved's profile picture. Controlling Inflammation is the only sustainable solution. Years of research are summarized here. The finer details are available on the stocktwits account.
3in5saved
@3in5saved
1 h

BP has a $230B patent cliff problem. Lung cancer drugs have a resistance problem. One oral drug addresses both. A paper sets the stage. nobrainerbio.substack.com/p/fp-4-the-pap… #NSCLC #Oncology #Biotech $IFRX

0
0
0
1
16
Charismaticrwa's profile picture. 从真实医疗产品与科研出发， 讨论 DePIN、RWA 如何进入医疗系统。 关注诊断、数据、科研资产， 以及医疗价值如何被验证与参与。 #Charismatic DePIN & RWA through real healthcare products and research.
Charismatic
 @Charismaticrwa
1 h

Web3 不缺飘在空中的协议，缺的是物理锚点。 我们的设备是生物真相与数字共识的硬接口。 它不只是一件产品，它是一座桥，强迫区块链停止空转，真正去承接现实世界的重量。 #Charismatic #Biotech #RWA #DeSci #VerifiableTruth #OnChainHealth

Charismaticrwa's tweet image. Web3 不缺飘在空中的协议，缺的是物理锚点。 我们的设备是生物真相与数字共识的硬接口。 它不只是一件产品，它是一座桥，强迫区块链停止空转，真正去承接现实世界的重量。 #Charismatic #Biotech #RWA #DeSci #VerifiableTruth #OnChainHealth
0
0
0
0
989
KELSEN_2006's profile picture. Leading Manufacturer of Air Purification & Bio-containment Solutions | 10+ Years of Expertise | Shipped Globally
KELSEN
 @KELSEN_2006
2 h

Need a prefabricated clean room cabin but tight on space? Meet our microbial inoculation room—a local purification powerhouse for: √ Pharmaceuticals √ Microbiological research √ Food safety labs 🔗en.ksncn.com/product-item-1… Plug-and-play design.Perfect for growing labs! #BioTech

KELSEN_2006's tweet image. Need a prefabricated clean room cabin but tight on space? Meet our microbial inoculation room—a local purification powerhouse for: √ Pharmaceuticals √ Microbiological research √ Food safety labs 🔗en.ksncn.com/product-item-1… Plug-and-play design.Perfect for growing labs! #BioTech
0
0
0
0
5
PacificCoastBio's profile picture. Our mission is to aid in the advancement of scientific discovery and human health by supplying affordable, high-quality cytokines for life science research
Pacific Coast Biologics
 @PacificCoastBio
2 h

Now available! 🚨 🚨 Animal Free recombinant human IL-15! Engineered for outstanding performance with an ED50 ≤ 0.3 ng/mL, corresponding to a specific activity ≥ 3 × 10^6 units/mg. Powerful and reliable! #Biotech #LifeSciences #Cytokines

PacificCoastBio's tweet image. Now available! 🚨 🚨 Animal Free recombinant human IL-15! Engineered for outstanding performance with an ED50 ≤ 0.3 ng/mL, corresponding to a specific activity ≥ 3 × 10^6 units/mg. Powerful and reliable! #Biotech #LifeSciences #Cytokines
0
0
0
0
5
orfgeotech's profile picture. Centre for Security, Strategy & Technology @orfonline.
ORF GeoTech
@orfgeotech
2 h

#AI–#biotech convergence and civil–#military applications heighten dual-use risks, making norms, multilateral frameworks, and the Biological Weapons Convention essential to safeguard innovation while managing #security: @lakshmyrkrish or-f.org/37605

orfgeotech's tweet card. Treating biotechnology as a strategic security asset deepens the dual-use dilemma, fuels techno-nationalist competition, fragments research cooperation, and risks worsening biosecurity unless managed...
Governing Biotechnology’s Dual-Use Security Dilemma
Source: orfonline.org
0
0
0
0
9
StockheadAU's profile picture. Big discoveries, amazing science, hot technology: Stockhead publishes exclusive news about emerging ASX-listed companies.
Stockhead
 @StockheadAU
3 h

Biocurious by Tim Boreham: A string of ASX drug developers are approaching pivotal clinical trial readouts in 2026 — here's what investors should have on their radar. #ASX #Biotech $DXB $CYP $RCE $NTI buff.ly/LQH31jG

StockheadAU's tweet card. A string of ASX-listed drug developers is due to release company-making – or breaking – pivotal clinical study results in coming months.
Biocurious: Stay tuned as drug developers get to the pointy end of their efforts | Stockhead
Source: stockhead.com.au
0
0
0
3
216
KnowB4UInvest's profile picture. I find the sharks before the feeding frenzy. $59B+ in verified prior exits. Same network. Same playbook. 384 targets identified. Public filings only. #biotech
Sentinel
 @KnowB4UInvest
3 h

SENTINEL is the next-generation ALPHA stock research platform. Easily helps you make well-informed trading decisions Deep data searches that leaves no stone un-turned Public Info ONLY! - clickable links We are the "Fly-on-the-Wall" #KnowB4UInvest #BioTech #fintech #stockmarket

0
0
0
0
11
orbital_station's profile picture. Orbital Insights: Space enthusiast exploring colonization, asteroid mining & way-out tech. Ideas, concepts, and prompts by Me. Written by AI
Orbital Insights
@orbital_station
4 h

ISS Expedition 74 crew advances space biotech: stem cell studies, plant-microbe interactions, worm adaptation & Earth observation ahead of cargo departure. nasa.gov/blogs/spacesta… #ISS #SpaceHealth #Biotech

orbital_station's tweet card. The trash-packed Progress 93 cargo spacecraft from Roscosmos will depart the International Space Station later today completing a seven-month mission docked to the Zvezda service module’s aft port.
Space Health Research Fills Day Before Cargo Craft Departs - NASA
Source: nasa.gov
0
0
0
0
3
NovaPressTT's profile picture.
NovaPress
 @NovaPressTT
4 h

Kelonia Therapeutics went from struggling to stay afloat to a $3.25B acquisition by Eli Lilly. Is this the ultimate blueprint for biotech survival or a lucky anomaly? 🧬🚀 👇 Read full story: thenovapress.vercel.app/post/1470 #Biotech #EliLilly

NovaPressTT's tweet image. Kelonia Therapeutics went from struggling to stay afloat to a $3.25B acquisition by Eli Lilly. Is this the ultimate blueprint for biotech survival or a lucky anomaly? 🧬🚀 👇 Read full story: thenovapress.vercel.app/post/1470 #Biotech #EliLilly
0
0
0
0
7
BioTechRandy1's profile picture. Tracking catalysts, clinical data, and small-cap chaos. Not advice
BioTech Randy
 @BioTechRandy1
5 h

Watching CRISPR Therapeutics as capital rotating into growth is pushing productivity higher. #Biotech #Healthcare

0
0
0
0
1
fklivestolearn's profile picture. Author, Researcher, #Crypto & Futures/Forex trader, #Tech freak, #Space buff and above all a #LifelongLearner - LinkTree: https://t.co/o2S3mzMWyj
Faisal Khan
 @fklivestolearn
5 h

Printed neurons that can communicate with real brain cells are no longer science fiction. This breakthrough could unlock: Brain-like, energy-efficient computing. #Innovation #Future #BioTech 👉 shorturl.at/FkLFC @technicitymag @gvalan @DrFerdowsi @junjudapi @mary_gambara

fklivestolearn's tweet image. Printed neurons that can communicate with real brain cells are no longer science fiction. This breakthrough could unlock: Brain-like, energy-efficient computing. #Innovation #Future #BioTech 👉 shorturl.at/FkLFC @technicitymag @gvalan @DrFerdowsi @junjudapi @mary_gambara
0
3
3
0
44
thakar_aum's profile picture. Tech / Economic Development/ Global Investments.
Aum Thakar
 @thakar_aum
6 h

Retail panic dumps $PBM while institutions buy 50K shares at $10. This is consolidation. With White House push to fast-track psychedelic treatments for PTSD & veterans (ibogaine), smart money sees $20 next. #PBM #Biotech 🚀

2
0
4
0
366
aimhifund's profile picture. We provide oncology startups with the resources they need to drive innovative discoveries forward to the people battling cancer!
AIM-HI Accelerator Fund
 @aimhifund
6 h

🚨 NIH Webinar: A First-in-Class Non-Opioid Therapy for Substance Use Disorders 🗓 April 29, 2026 | ⏰ 11:00 AM – 12:00 PM (EST) Ideal for biotech/pharma leaders, investors, and BD professionals. 🔗 Register to attend: hubs.ly/Q04cZ9m30 #Biotech #DrugDevelopment #NIH

aimhifund's tweet image. 🚨 NIH Webinar: A First-in-Class Non-Opioid Therapy for Substance Use Disorders 🗓 April 29, 2026 | ⏰ 11:00 AM – 12:00 PM (EST) Ideal for biotech/pharma leaders, investors, and BD professionals. 🔗 Register to attend: hubs.ly/Q04cZ9m30 #Biotech #DrugDevelopment #NIH
0
0
1
0
5
PPietrack91809's profile picture.
Pharmaverse Podcast Michael Pietrack
 @PPietrack91809
7 h

What happens when your personal life shapes your professional mission? 🎙️ Dr. Christiane Langer explores how personal experiences can influence work and how to protect work-life balance. #Pharma #Biotech #Oncology #Leadership #WorkLifeBalance #CareerGrowth #Podcast

0
0
0
0
1
yamaybioinc's profile picture. Innovative biological reagents for life science research and the biotech industry.
Yamaybio
 @yamaybioinc
7 h

Buffalo: we’re here tomorrow! Join us at the University at Buffalo Research Supplier Product Show 📍 Jacobs School of Medicine ⏰ 11:30 AM – 1:30 PMStop by for a FREE sample 👀#Biotech #LabLife #Science #Research #YamayBio #ScientistSolutions #UBuffalo #WetLab #Innovation

yamaybioinc's tweet image. Buffalo: we’re here tomorrow! Join us at the University at Buffalo Research Supplier Product Show 📍 Jacobs School of Medicine ⏰ 11:30 AM – 1:30 PMStop by for a FREE sample 👀#Biotech #LabLife #Science #Research #YamayBio #ScientistSolutions #UBuffalo #WetLab #Innovation
0
0
0
0
8
DylanInvest's profile picture. Burn rate, ATM usage, warrants overhang, vendor debt. Pre-rev risk quantified. Not advice.
Dylan
 @DylanInvest
7 h

Moderna tied to automation in logistics is attracting institutional attention. #Innovation #Biotech

0
0
0
0
1
inhibrx's profile picture. Innovation Focused Outcomes Driven Biotechnology Research
Inhibrx Biosciences, Inc.
 @inhibrx
7 h

Inhibrx is excited to share a clinical update on ozekibart (INBRX-109) in late line colorectal cancer. Read the full press release on our website: tinyurl.com/3dncyvf6 #Biotech #INBRX109 #INHIBRX

inhibrx's tweet image. Inhibrx is excited to share a clinical update on ozekibart (INBRX-109) in late line colorectal cancer. Read the full press release on our website: tinyurl.com/3dncyvf6 #Biotech #INBRX109 #INHIBRX
0
0
3
0
51
learnbiotech's profile picture. Learn to invest in biotech like the professionals from a former biotech executive and investment banker. For education purposes only. Course on Thinkific
Biotech Investor
@learnbiotech
Apr 6

Investors should look at fully diluted shares outstanding #FDSO when looking at the market cap of a company. Dilutive securities, including options, warrants, converts, etc, can have a meaningful impact on the actual market cap of a company #learnbiotechinvesting #biotech

learnbiotech's tweet image. Investors should look at fully diluted shares outstanding #FDSO when looking at the market cap of a company. Dilutive securities, including options, warrants, converts, etc, can have a meaningful impact on the actual market cap of a company #learnbiotechinvesting #biotech
0
0
2
4
842
ISS_CASIS's profile picture. The International Space Station National Laboratory is managed by the Center for the Advancement of Science in Space (CASIS).
ISS National Lab
 @ISS_CASIS
15 h

In microgravity, cells can’t always access what they need to produce efficiently. Fixing space manufacturing may mean redesigning how they’re grown: ow.ly/ACfQ50YJXoK #SpaceBiology #Microgravity #Biotech #ISSResearch #Innovation #SpaceX

ISS_CASIS's tweet image. In microgravity, cells can’t always access what they need to produce efficiently. Fixing space manufacturing may mean redesigning how they’re grown: ow.ly/ACfQ50YJXoK #SpaceBiology #Microgravity #Biotech #ISSResearch #Innovation #SpaceX
0
3
10
1
628
EURESJob's profile picture. EURES supports EU/EEA resident jobseekers to work abroad, and employers to recruit international employees. #EURESjobs
EURES
 @EURESJob
Apr 15

If you're a professional in #ICT, #biotech or #cleantech, Valais is hiring! Join the #WorkinginValais event on 23 April from 10:00 to 12:30 CET to: 💼 Browse open vacancies 🤝 Chat with employers 📝 Learn about working in Valais Register 👉 europeanjobdays.eu/en/event/work-… #EURESJobs

EURESJob's tweet image. If you're a professional in #ICT, #biotech or #cleantech, Valais is hiring! Join the #WorkinginValais event on 23 April from 10:00 to 12:30 CET to: 💼 Browse open vacancies 🤝 Chat with employers 📝 Learn about working in Valais Register 👉 europeanjobdays.eu/en/event/work-… #EURESJobs
1
1
2
1
448
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
Apr 2

All in all, it was a strong first quarter for the #biotech sector, marked by a high level of M&A activity that is set to continue. I’d like to wish you and your families a happy Easter. I hope you enjoy my posts and ideas! 🙏 $XBI $TERN $DAWN $APLS $VTYX $CNTA $ACLX

doepke_michel's tweet image. All in all, it was a strong first quarter for the #biotech sector, marked by a high level of M&A activity that is set to continue. I’d like to wish you and your families a happy Easter. I hope you enjoy my posts and ideas! 🙏 $XBI $TERN $DAWN $APLS $VTYX $CNTA $ACLX
0
0
18
0
1K
kkernttb's profile picture. Full time trader, sharing ideas
kkern
@kkernttb
Apr 15

$IBB #biotech back to major resistance line

kkernttb's tweet image. $IBB #biotech back to major resistance line
0
0
0
0
848
DirectorsTalk's profile picture. DirectorsTalk are the most followed news portal in the UK for London Stock Exchange news, research & interviews with Directors of leading PLCs.
DirectorsTalk
@DirectorsTalk
Apr 13

Genflow Biosciences eyes pivotal catalysts across MASH, glaucoma and animal health (video) tinyurl.com/26nn7y4j #GENF #GenflowBiosciences #Biotech #MASH #Glaucoma #Stocks

DirectorsTalk's tweet image. Genflow Biosciences eyes pivotal catalysts across MASH, glaucoma and animal health (video) tinyurl.com/26nn7y4j #GENF #GenflowBiosciences #Biotech #MASH #Glaucoma #Stocks
0
0
0
0
184
learnbiotech's profile picture. Learn to invest in biotech like the professionals from a former biotech executive and investment banker. For education purposes only. Course on Thinkific
Biotech Investor
@learnbiotech
Apr 7

Incorporating Probability of Success (PoS) is a unique aspect of #biotech valuation investors must be aware of. It tries to factor development risk into revenue and cost assumptions. Here is a table of PoS values: #learnbiotechinvesting #investing #BiotechPrometheus

learnbiotech's tweet image. Incorporating Probability of Success (PoS) is a unique aspect of #biotech valuation investors must be aware of. It tries to factor development risk into revenue and cost assumptions. Here is a table of PoS values: #learnbiotechinvesting #investing #BiotechPrometheus
0
0
7
7
1K
ElliottForecast's profile picture. Global community of traders mastering Elliott Wave. 78 markets, expert insights & Blue Box setups. Educational only! https://t.co/YiwKvHhIdO
Elliottwave Forecast
@ElliottForecast
Apr 13

Have you noticed how $XBI hasn’t started Wave II yet? 👀 When Wave I extends like this, the next pullback often catches traders off guard. If you want to read the cycle with precision, check this 👉 elliottwave-forecast.com #Stocks #Biotech #Elliottwave

ElliottForecast's tweet image. Have you noticed how $XBI hasn’t started Wave II yet? 👀 When Wave I extends like this, the next pullback often catches traders off guard. If you want to read the cycle with precision, check this 👉 elliottwave-forecast.com #Stocks #Biotech #Elliottwave
0
0
1
1
569
AusOfficeTPE's profile picture. Robert Fergusson, Representative, Australian Office, Taipei. Consular assistance: (02)8725 4100 Taiwan or 1300 555 134 Australia. Travel updates @Smartraveller
Robert Fergusson
 @AusOfficeTPE
14 h

Great to host a group of #biotech and #pharmaceutical #leaders, together with our special guest, Professor Sharon Lewin AO. #Australia #Taiwan @TheDohertyInst @Austrade

AusOfficeTPE's tweet image. Great to host a group of #biotech and #pharmaceutical #leaders, together with our special guest, Professor Sharon Lewin AO. #Australia #Taiwan @TheDohertyInst @Austrade
1
0
5
0
155
EU_Startups's profile picture. European startups, entrepreneurs, business angels, and venture capitalists - welcome to the news feed for https://t.co/Dp7XYJRRjv 🇪🇺🚀
EU-Startups
@EU_Startups
Apr 16

Cambridge-based @STORMTherapeutics, a #BioTech company targeting #RNA modifications to reprogram cells and develop novel #cancer therapies, today announced that it has secured €47.5 million in Series C financing. 🇬🇧 🧬💉 eu-startups.com/2026/04/storm-…

EU_Startups's tweet image. Cambridge-based @STORMTherapeutics, a #BioTech company targeting #RNA modifications to reprogram cells and develop novel #cancer therapies, today announced that it has secured €47.5 million in Series C financing. 🇬🇧 🧬💉 eu-startups.com/2026/04/storm-…
0
1
2
0
181
LongevityTech's profile picture. Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity
Longevity Technology
 @LongevityTech
Apr 14

Parkinson’s drug shows unexpected effects, highlighting how targeting complex brain pathways can backfire in clinical development. ㅤ Link in bio. ㅤ #longevity #parkinsons #biotech #healthspan #innovation

LongevityTech's tweet image. Parkinson’s drug shows unexpected effects, highlighting how targeting complex brain pathways can backfire in clinical development. ㅤ Link in bio. ㅤ #longevity #parkinsons #biotech #healthspan #innovation
0
1
7
1
712
ElliottForecast's profile picture. Global community of traders mastering Elliott Wave. 78 markets, expert insights & Blue Box setups. Educational only! https://t.co/YiwKvHhIdO
Elliottwave Forecast
@ElliottForecast
Apr 10

Have you noticed how $XBI hasn’t started Wave II yet? 👀 When Wave I extends like this, the next pullback often catches traders off guard. If you want to read the cycle with precision, check this 👉 elliottwave-forecast.com #Stocks #Biotech #Elliottwave

ElliottForecast's tweet image. Have you noticed how $XBI hasn’t started Wave II yet? 👀 When Wave I extends like this, the next pullback often catches traders off guard. If you want to read the cycle with precision, check this 👉 elliottwave-forecast.com #Stocks #Biotech #Elliottwave
0
1
1
1
666
DanielNorero's profile picture. #Biotech, AgTech, AgBusiness | Neocrop Technologies (Co-Founder)🌱🧬 | BTI @ScienceAlly Fellow | Echando raíces en Valdivia y alguna vez fui triatleta 🇨🇱🇮🇹
Daniel Norero
@DanielNorero
Apr 6

Engineered tobacco plant can produce five psychedelics, including psilocybin and DMT 🧠🌵🌱🧪phys.org/news/2026-04-t… #psychedelics #biotech #plants #psilocybin #DMT #science #psychiatry

DanielNorero's tweet image. Engineered tobacco plant can produce five psychedelics, including psilocybin and DMT 🧠🌵🌱🧪phys.org/news/2026-04-t… #psychedelics #biotech #plants #psilocybin #DMT #science #psychiatry
0
2
1
0
679
LongevityTech's profile picture. Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity
Longevity Technology
 @LongevityTech
Apr 13

Alzheimer’s drug clears Phase 2a with early signals it may be targeting neuroinflammation—not just symptoms. ㅤ Link in bio. ㅤ #longevity #alzheimers #biotech #healthspan #brainhealth

LongevityTech's tweet image. Alzheimer’s drug clears Phase 2a with early signals it may be targeting neuroinflammation—not just symptoms. ㅤ Link in bio. ㅤ #longevity #alzheimers #biotech #healthspan #brainhealth
2
8
25
2
1K
markgardn's profile picture. Views expressed my opinions, not advice from MPC Markets Finance contributor to Reuters, AusbizTV, Livewire Markets, FNArena, Sky News, SMH, The Age and SBS
Mark Gardner
@markgardn
Apr 13

A huge morning for Telix $TLX 🔬 The Regeneron collab is a game-changer: 🔹 US$40M upfront 🔹 50/50 profit split or $2.1B milestones 🔹 Pixclara PDUFA: 11 Sept Broker targets ($19–$32) don't even model this yet. Full breakdown: ap1.hubs.ly/y0LLmb0 #ASX #Biotech

markgardn's tweet image. A huge morning for Telix $TLX 🔬 The Regeneron collab is a game-changer: 🔹 US$40M upfront 🔹 50/50 profit split or $2.1B milestones 🔹 Pixclara PDUFA: 11 Sept Broker targets ($19–$32) don't even model this yet. Full breakdown: ap1.hubs.ly/y0LLmb0 #ASX #Biotech
2
1
18
1
1K
LongevityTech's profile picture. Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity
Longevity Technology
 @LongevityTech
Apr 17

RNA editing enters the clinic as AIRNA doses its first patient, advancing a new class of therapies that repair genetic mutations without altering DNA. ㅤ Link in bio. ㅤ #longevity #biotech #rna #healthspan #innovation

LongevityTech's tweet image. RNA editing enters the clinic as AIRNA doses its first patient, advancing a new class of therapies that repair genetic mutations without altering DNA. ㅤ Link in bio. ㅤ #longevity #biotech #rna #healthspan #innovation
0
7
25
6
857
LongevityTech's profile picture. Daily news and insights on research, investments and technologies that extend life and improve the quality of that extended life. #Longevity
Longevity Technology
 @LongevityTech
Apr 14

Oral Alzheimer’s pipeline advances as biotech pushes for scalable, disease-modifying treatments beyond infusions. ㅤ Link in bio. ㅤ #longevity #alzheimers #biotech #healthspan #innovation

LongevityTech's tweet image. Oral Alzheimer’s pipeline advances as biotech pushes for scalable, disease-modifying treatments beyond infusions. ㅤ Link in bio. ㅤ #longevity #alzheimers #biotech #healthspan #innovation
0
2
11
0
590

Something went wrong.


Something went wrong.


United States Trends